{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:51:25Z","timestamp":1790193085651,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jcjd.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:37:12Z","timestamp":1625791032000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 Diabetes"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-9625","authenticated-orcid":false,"given":"Jiabi","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Al Sayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-2857","authenticated-orcid":false,"given":"Jeffrey A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0381-5980","authenticated-orcid":false,"given":"Mike","family":"Paulden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-1573","authenticated-orcid":false,"given":"Arto","family":"Ohinmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/j.jcjd.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcjd.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12913-015-0687-5","article-title":"Economic burden of illness associated with diabetic foot ulcers in Canada","volume":"15","author":"Hopkins","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jcjd.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2337\/diacare.26.5.1435","article-title":"Diabetic foot syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort","volume":"26","author":"Lavery","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/dme.13054","article-title":"Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom","volume":"33","author":"Walsh","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/2042018813489719","article-title":"Improving major amputation rates in the multicomplex diabetic foot patient: Focus on the severity of peripheral arterial disease","volume":"4","author":"Brechow","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8727(00)00133-1","article-title":"Health-related quality of life in patients with diabetes mellitus and foot ulcers","volume":"14","author":"Ragnarson Tennvall","year":"2000","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jcjd.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.2337\/diacare.25.12.2238","article-title":"Valuing health-related quality of life in diabetes","volume":"25","author":"Coffey","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1534734609336948","article-title":"Emerging evidence for neuroischemic diabetic foot ulcers: Model of care and how to adapt practice","volume":"8","author":"Ndip","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.jcjd.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2213-8587(17)30438-2","article-title":"Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): An international, multicentre, double-blind, randomised, controlled trial","volume":"6","author":"Edmonds","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcjd.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1177\/193229681100500636","article-title":"Diabetic foot ulcers and vascular insufficiency: Our population has changed, but our methods have not","volume":"5","author":"Armstrong","year":"2011","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2021.07.001_bib14","unstructured":"National Institute for Health and Care Excellence. Medical Technologies Guidance MTG42. UrgoStart for Treating Diabetic Foot Ulcers and Leg Ulcers 2019. https:\/\/www.nice.org.uk\/guidance\/MTG42\/history."},{"key":"10.1016\/j.jcjd.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.12968\/jowc.2019.28.12.808","article-title":"Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers","volume":"28","author":"Lobmann","year":"2019","journal-title":"J\u00a0Wound Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245652","article-title":"Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France","volume":"16","author":"Maunoury","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.12968\/jowc.2019.28.8.543","article-title":"Implementation of NICE technology guidance on venous leg ulcers and diabetic foot ulcers: A conference report","volume":"28","author":"Cowan","year":"2019","journal-title":"J\u00a0Wound Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib18","series-title":"Assessment and Management of Foot Ulcers for People With Diabetes","year":"2013"},{"key":"10.1016\/j.jcjd.2021.07.001_bib19","series-title":"Guidelines for the Economic Evaluation of Health Technologies: Canada","year":"2017"},{"key":"10.1016\/j.jcjd.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1742-481X.2012.01022.x","article-title":"Risk factors for recurrence of diabetic foot ulcers: Prospective follow-up analysis in the Eurodiale subgroup","volume":"10","author":"Dubsk\u00fd","year":"2013","journal-title":"Int Wound J"},{"key":"10.1016\/j.jcjd.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.2337\/dc12-2085","article-title":"Comment on: Bernstein. Reducing foot wounds in diabetes","volume":"36","author":"Morbach","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.2014.59.7245","article-title":"Economic evaluation of bevacizumab for the first-line treatment of newly diagnosed glioblastoma multiforme","volume":"33","author":"Kovic","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcjd.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.diabres.2018.05.004","article-title":"Perioperative and long-term all-cause mortality in patients with diabetes who underwent a lower extremity amputation","volume":"141","author":"L\u00f3pez-Valverde","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/iwj.12249","article-title":"Clinical outcomes of toe amputation in patients with type 2 diabetes in Tianjin, China","volume":"13","author":"Chu","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.jcjd.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2337\/dc09-0651","article-title":"History of foot ulcer increases mortality among individuals with diabetes: Ten-year follow-up of the Nord-Trondelag Health Study, Norway","volume":"32","author":"Iversen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib27","first-page":"1","article-title":"Best practice guidelines: Wound management in diabetic foot ulcers","volume":"1","author":"Chadwick","year":"2013","journal-title":"Wounds Int"},{"key":"10.1016\/j.jcjd.2021.07.001_bib28","unstructured":"Urgo Medical. UrgoStart Contact. Wound contact dressings. Protease modulating dressings. Wound care handbook. https:\/\/www.woundcarehandbook.com\/product\/548\/urgostart_contact. Accessed March 23, 2019."},{"key":"10.1016\/j.jcjd.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"E486","DOI":"10.9778\/cmajo.20180088","article-title":"Cost-effectiveness of telemonitoring screening for diabetic foot ulcer: A mathematical model","volume":"6","author":"Boodoo","year":"2018","journal-title":"CMAJ Open"},{"issue":"Suppl","key":"10.1016\/j.jcjd.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.jcjd.2015.05.005","article-title":"The Alberta\u2019s Caring for Diabetes (ABCD) study: Rationale, design and baseline characteristics of a prospective cohort of adults with type 2 diabetes","volume":"39","author":"Sayah","year":"2015","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","article-title":"A\u00a0time trade-off-derived value set of the EQ-5D-5L for Canada","volume":"54","author":"Xie","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcjd.2016.06.007","article-title":"Outcomes following advanced wound care for diabetic foot ulcers: A Canadian study","volume":"41","author":"Roth-Albin","year":"2017","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7547\/0980489","article-title":"Mortality rates and diabetic foot ulcers: Is it time to communicate mortality risk to patients with diabetic foot ulceration?","volume":"98","author":"Robbins","year":"2008","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"key":"10.1016\/j.jcjd.2021.07.001_bib34","first-page":"967","article-title":"Recurrence of neuropathic ulceration following healing in a total contact cast","volume":"72","author":"Helm","year":"1991","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jcjd.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00125-008-1226-2","article-title":"Complexity of factors related to outcome of neuropathic and neuroischaemic\/ischaemic diabetic foot ulcers: A cohort study","volume":"52","author":"Gershater","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2021.07.001_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5694\/j.1326-5377.2000.tb125685.x","article-title":"Diabetes-related lower-limb amputations in Australia","volume":"173","author":"Payne","year":"2000","journal-title":"Med J Aust"},{"key":"10.1016\/j.jcjd.2021.07.001_bib37","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.25.10.1835","article-title":"Diabetic neuropathic foot ulcers: The association of wound size, wound duration, and wound grade on healing","volume":"25","author":"Margolis","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2021.07.001_bib38","doi-asserted-by":"crossref","first-page":"e0177176","DOI":"10.1371\/journal.pone.0177176","article-title":"Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: A retrospective cohort study","volume":"12","author":"Smith-Str\u00f8m","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2021.07.001_bib39","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamadermatol.2013.4960","article-title":"Frequency of debridements and time to heal: A retrospective cohort study of 312 744 wounds","volume":"149","author":"Wilcox","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jcjd.2021.07.001_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/027298902400448902","article-title":"Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)","volume":"22","author":"Clarke","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jcjd.2021.07.001_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jval.2014.03.003","article-title":"Review of utility values for economic modeling in type 2 diabetes","volume":"17","author":"Beaudet","year":"2014","journal-title":"Value Health"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267121001933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267121001933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:37:54Z","timestamp":1761493074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267121001933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1499267121001933"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2021.07.001","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}